Novo Nordisk says Catalent buyout to close soon

Indications are that Novo will be investing in both the plant and the community,” an Indiana University professor said.
After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to ...
Novo Holdings can proceed with its planned $16.5 billion acquisition of Catalent after U.S. regulators declined to challenge ...
Novo Holdings is on track to acquire Catalent, a global contract development and manufacturing organization, in a $16.5 ...
The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...
Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) announced plans to invest approximately $1.20 billion (8.5 billion ...
Years of layoffs and alleged mismanagement have left employees “sick” of the pharmaceutical contract manufacturer Catalent, ...
The latest update is out from Novo Nordisk ( (NVO) ).
Ozempic maker Novo Nordisk A/S is investing 8.5 billion kroner ($1.2 billion) to build a new major factory in Denmark to help ...
Novo Nordisk is investing $1.2 billion in a rare disease drugs facility in Denmark, weight-loss drugs surge American ...